Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Revenue

Arbutus Biopharma had revenue of $10.74M in the quarter ending June 30, 2025, with 522.19% growth. This brings the company's revenue in the last twelve months to $15.42M, up 53.23% year-over-year. In the year 2024, Arbutus Biopharma had annual revenue of $6.17M, down -65.98%.

• Revenue (ttm): $15.42M
• Revenue Growth: +53.23%
• P/S Ratio: 59.67
• Revenue / Employee: $350,364
• Employees: 44
• Market Cap: 927.82M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.17M	-11.97M	-65.98%
Dec 31, 2023	18.14M	-20.88M	-53.51%
Dec 31, 2022	39.02M	28.03M	255.11%
Dec 31, 2021	10.99M	4.07M	58.92%
Dec 31, 2020	6.91M	903.00K	15.02%